Lung Cancer Trial, Recruiting (NCT05819346)

Lung Cancer Trial, Recruiting NCT05819346 Sponsor: Kai-Uwe Schmitt, PhD, MEng, ICID Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05819346 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 years or older
People who have been diagnosed with non-small cell lung cancer (a common type of lung cancer)
People whose doctors estimate they have a life expectancy of at least six months
People who are currently taking part in inpatient or outpatient rehabilitation, or who have finished planned surgery, chemotherapy, or radiation therapy for their lung cancer within the past 24 weeks
People who have enough knowledge of German to understand the study materials and complete assessments
People who have access to a mobile phone or tablet
People who are willing and able to provide written consent to take part

Who may not be able to join:

People who are not able to give informed consent to participate in the trial
People who are unable to take part in the trial's activities due to physical, cognitive (thinking or memory), or safety-related reasons, as judged by the local medical team

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anja Frei, PhD, University of Zurich

Phone: +41 44 634 43 60

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05819346

Sponsor: Kai-Uwe Schmitt, PhD, MEng, ICID

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

Trial contact: +41 44 634 43 60

More information: https://clinicaltrials.gov/study/NCT05819346

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 years or older
People who have been diagnosed with non-small cell lung cancer (a common type of lung cancer)
People whose doctors estimate they have a life expectancy of at least six months
People who are currently taking part in inpatient or outpatient rehabilitation, or who have finished planned surgery, chemotherapy, or radiation therapy for their lung cancer within the past 24 weeks
People who have enough knowledge of German to understand the study materials and complete assessments
People who have access to a mobile phone or tablet
People who are willing and able to provide written consent to take part

Who may not be able to join:

People who are not able to give informed consent to participate in the trial
People who are unable to take part in the trial's activities due to physical, cognitive (thinking or memory), or safety-related reasons, as judged by the local medical team

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Kai-Uwe Schmitt, PhD, MEng, ICID

Registry

ClinicalTrials.gov

Start date

1 August 2023

Est. completion

1 December 2025

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Health-related quality of life (Scale-Global health status)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov